US377373AM70 · Corp · USD

Glaxosmithkline Capital Plc 4.32% 2027/03

MID PRICE
100.80
par = 100
YIELD TO MAT.
4.04%
semi-annual
COUPON
4.320%
semi-annual · fixed
MATURITY
2027-03-12
bullet · 0.85y
OUTSTANDING
not disclosed
AS OF
2026-04-30
Fund disclosure

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
0.83 y
1bp ↑ ≈ -0.008% P&L
Convexity
1.09
higher = more curvature
Years to maturity
0.85 y
YTM source
Ingested
Fund disclosure
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares iBonds Dec 2027 Term Corporate
iShares
iBonds 2027 Corporate$2.8M▲ $8300.07%2026-04-30
State Street Ultra Short Term Bond
SPDR
US Ultra Short$210K▲ $380.04%2026-04-30
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-04-30

Institutional footprint · signal-level holdings

19/ 100Minimal footprint
Interpretation. Minimal institutional footprint, holding
HOLDERS
2
unchanged in 7d
AGGREGATE EXPOSURE
$3.0M
USD across all
TOP CONCENTRATION
93.0%
largest holder
FLOW
▲ $5K
unchanged in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
100,801 USD
PRICE
100.80

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
GSK 4.315 03/12/27
FIGI
BBG01SQ8W2K9
CUSIP
377373AM7
ISIN
US377373AM70
Type
Corp
Issued
2025-03-13
Face value
100 USD
Ticker
GSK 4.315 03/12/27
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

GSK · 4 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.